急性白血病药物治疗研究进展

被引：4

作者：

王丽

蒋慧

机构：

[1] 上海交通大学附属上海市儿童医院血液肿瘤科

来源：

世界临床药物 | 2011年 / 32卷 / 03期

关键词：

白血病; 急性; 核苷酸类似物; 靶向治疗;

D O I：

暂无

中图分类号：

R733.71 [急性白血病];

学科分类号：

100214 ;

摘要：

急性白血病(AL)化疗耐药及复发是影响患者预后的重要原因。随着分子生物学及免疫学的研究发展,AL治疗新药研发进展迅速,本文综述核苷酸类似物、分子靶向治疗药物和多药耐药逆转剂等临床AL治疗新思路。

引用

页码：176 / 180

页数：5

共 6 条

[1] 抗急性髓系白血病的新药研发综述 [J].

向恢晖 ;

李玛琳 ;

翁稚颖 .

中国医药指南, 2010, 8 (21) :30-33

[2]

FLUDARABINE, CYTARABINE, GRANULOCYTE COLONY-STIMULATING FACTOR, AND IDARUBICIN (FLAG-IDA) FOR THE TREATMENT OF CHILDREN WITH POOR-PROGNOSIS ACUTE LEUKEMIA: The Hacettepe Experience[J] . Betul Tavil,Selin Aytac,Yasemin Is&inodot,k Balc&inodot,Sule Unal,Bar&inodot,s Kuskonmaz,Sevgi Yetgin,Aytemiz Gurgey,Murat Tuncer,Fatma Gumruk,Duygu Uckan,Mualla Cetin.Pediatric Hematology-Oncology . 2010 (7)

[3]

A new high-performance liquid chromatography method determines low productionof 9-β-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine,in adult T-cell leukemia cells[J] . Takahiro Yamauchi,Rie Nishi,Kazuhiro Kitazumi,Tsuyoshi Nakano,Takanori Ueda.Oncology Reports . 2010 (2)

[4]

Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia[J] . Dave Kisor,Kelly Reilly.OncoTargets and Therapy . 2009 (defa)

[5] Acute lymphoblastic leukaemia [J].

Pui, Ching-Hon ;

Robison, Leslie L. ;

Look, A. Thomas .

LANCET, 2008, 371 (9617) :1030-1043

[6]

192 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the anti-CD19-DM4 conjugated antibody SAR3419[J] . R. Lock,H. Carol,P. Houghton,C. Morton,D. Phelps,C. Tucker,D. Payne-Turner,C. Zuany-Amorim,M. Smith.EJC Supplements . 2008 (12)

← 1 →